Titan International, Inc.
NYSE:TWIAgricultural - Machinery
+$0.24 today
- Market cap
- $283.62M
- Beta
- 1.47
- P/E (TTM)
- -5.6
- EPS (TTM)
- -$1.36
Volume 0.77M
Average 0.93M
TWI Depreciation & Amortization
Non-cash expense that spreads the cost of physical and intangible assets over their useful lives.
Titan International, Inc.NYSE: TWI
Depreciation & Amortization · Q1 FY2026 · quarter ended Mar 2026
Depreciation & amortization grows in line with its trailing trend
Q1 FY2026 depreciation & amortization of $17.07M rose 7.6% year over year, ahead of the +5.8% change in trailing-twelve-month depreciation & amortization. Sequentially, it fell 4.2% from the prior quarter. Over 3 fiscal years it compounded at +17.0% a year.
Context
- Depreciation & amortization amounted to 3.7% of revenue in FY2025, up 0.4 pp from a year earlier.
- Depreciation & amortization increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth of +7.6% holds above the trailing-twelve-month pace of +5.8%.
Sources:Income StatementText generated from reported figures; not investment advice.
Depreciation & Amortization history
USD · from the income statement
- Latest · FY2025
- 67.11M USD
- Year-over-year change
- +10.6%
- 4-year CAGR
- +9.3%
| Period | Period end | Depreciation & Amortization | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 67.11M | +10.6% |
| FY2024 | 2024-12-31 | 60.7M | +43.1% |
| FY2023 | 2023-12-31 | 42.43M | +1.3% |
| FY2022 | 2022-12-31 | 41.9M | -10.9% |
| FY2021 | 2021-12-31 | 47M | — |
Depreciation & Amortization vs competitors
How TWI compares with its peers on the latest reported figures
- TWI's LTM Mar 2026 depreciation & amortization of $68.31M is the 4th highest of the 11 companies compared; the peer median is $49.94M.
- Its year-over-year change of +5.8% is the 5th highest of 11, against a peer median of +2.7%.
- Depreciation & amortization amounts to 3.7% of revenue for TWI, versus a peer median of 7.7%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $137.56M | -5.4% | +7.3% | 7.4% | |
| LTM Mar 2026 | $94.91M | +8.8% | +19.9% | 7.9% | |
| LTM Mar 2026 | $77.04M | +59.9% | +15.6% | 6.5% | |
| LTM Mar 2026 | $68.31M | +5.8% | +17.0% | 3.7% | |
| LTM Mar 2026 | $62.3M | -1.3% | -0.4% | 2.8% | |
| LTM Mar 2026 | $59.58M | +1.9% | +6.5% | 20.8% | |
| LTM Mar 2026 | $40.3M | +30.3% | +5.0% | 12.4% | |
| LTM Mar 2026 | $29M | +3.6% | +0.0% | 2.7% | |
| LTM Mar 2026 | $26.47M | -14.4% | +11.0% | 14.5% | |
| LTM Mar 2026 | $12.5M | -3.0% | +7.8% | 14.2% | |
SRTAStrata Critical Medical, Inc. | LTM Mar 2026 | $9.55M | +57.4% | +6.4% | 3.8% |
| Peer median (excluding TWI) | $49.94M | +2.7% | +6.9% | 7.7% | |
Competitors are the stored peer set for TWI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 1.78B | 2.17B | 1.82B | 1.85B | 1.83B |
| Cost of Revenue | 1.54B | 1.81B | 1.52B | 1.59B | 1.59B |
| Gross Profit | 237.54M | 360.71M | 305.85M | 257.8M | 242.35M |
| Gross Margin | 13.3% | 16.6% | 16.8% | 14.0% | 13.3% |
| Research & Development | 10.1M | 10.4M | 12.54M | 16.52M | 18.32M |
| Selling, General & Admin | 131.77M | 132.79M | 134.94M | 191.79M | 203.27M |
| Operating Expenses | 152.37M | 154.91M | 157.12M | 224.62M | 221.59M |
| Depreciation & Amortization | 47M | 41.9M | 42.43M | 60.7M | 67.11M |
| EBITDA | 130.26M | 274.05M | 170.97M | 105.4M | 94.52M |
| EBITDA Margin | 7.3% | 12.6% | 9.4% | 5.7% | 5.2% |
| Operating Income | 85.18M | 205.8M | 148.73M | 33.18M | 20.76M |
| Operating Margin | 4.8% | 9.5% | 8.2% | 1.8% | 1.1% |
| Interest Income | 0 | 2.35M | 0 | 11.02M | 10.7M |
| Interest Expense | 32.22M | 32.15M | 18.79M | 36.43M | 38.71M |
| Other Income / Expenses | (34.14M) | (3.45M) | (38.98M) | (24.91M) | (32.06M) |
| Income Before Tax | 51.04M | 202.35M | 109.75M | 8.27M | (11.3M) |
| Pre-Tax Margin | 2.9% | 9.3% | 6.0% | 0.4% | -0.6% |
| Income Tax Expense | 1.15M | 23.17M | 26.04M | 11.86M | 49.89M |
| Net Income | 49.59M | 176.3M | 78.76M | (5.56M) | (63.49M) |
| Net Margin | 2.8% | 8.1% | 4.3% | -0.3% | -3.5% |
| EPS (Basic) | 0.80 | 2.80 | 1.26 | (0.08) | (1.00) |
| EPS (Diluted) | 0.79 | 2.77 | 1.25 | (0.08) | (1.00) |
| Weighted Avg Shares | 62.1M | 63.04M | 62.45M | 68.66M | 63.49M |
| Weighted Avg Shares (Diluted) | 62.69M | 63.69M | 62.96M | 68.66M | 63.71M |
Titan International, Inc.
NYSE:TWI
Intrinsic Alpha fair value
Locked
Current Price
$4.39
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.